02/14/2025 8:00 AM | ACADIA Pharmaceuticals (Subject) RTW INVESTMENTS, LP (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025 5:04 AM | ACADIA Pharmaceuticals (Subject) BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
12/11/2024 3:22 PM | ACADIA Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/10/2024 5:33 PM | ACADIA Pharmaceuticals (Issuer) Garner Thomas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 5:31 PM | ACADIA Pharmaceuticals (Issuer) Garner Thomas (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/19/2024 7:40 PM | ACADIA Pharmaceuticals (Issuer) Schneyer Mark C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/19/2024 7:41 PM | ACADIA Pharmaceuticals (Issuer) Kihara James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/19/2024 7:43 PM | ACADIA Pharmaceuticals (Issuer) Teehan Brendan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2024 5:48 AM | ACADIA Pharmaceuticals (Subject) RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
10/15/2024 5:05 PM | ACADIA Pharmaceuticals (Issuer) Ndu Adora (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2024 5:46 PM | ACADIA Pharmaceuticals (Issuer) Adams Catherine Owen (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for ACAD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ACADIA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
09/25/2024 5:53 PM | ACADIA Pharmaceuticals (Issuer) Adams Catherine Owen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/23/2024 4:14 PM | ACADIA Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/23/2024 3:34 PM | ACADIA Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/20/2024 5:40 PM | ACADIA Pharmaceuticals (Issuer) DAVIS STEPHEN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 5:43 PM | ACADIA Pharmaceuticals (Issuer) Teehan Brendan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 5:46 PM | ACADIA Pharmaceuticals (Issuer) Schneyer Mark C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 3:37 PM | ACADIA Pharmaceuticals (Filer)
| Form S-8 POS | |
08/20/2024 3:39 PM | ACADIA Pharmaceuticals (Filer)
| Form S-8 POS | |
08/20/2024 3:23 PM | ACADIA Pharmaceuticals (Filer)
| Form S-8 POS | |
08/20/2024 3:25 PM | ACADIA Pharmaceuticals (Filer)
| Form S-8 POS | |
08/20/2024 3:27 PM | ACADIA Pharmaceuticals (Filer)
| Form S-8 POS | |
08/20/2024 3:29 PM | ACADIA Pharmaceuticals (Filer)
| Form S-8 POS | |
08/20/2024 3:31 PM | ACADIA Pharmaceuticals (Filer)
| Form S-8 POS | |
08/20/2024 3:33 PM | ACADIA Pharmaceuticals (Filer)
| Form S-8 POS | |
08/13/2024 5:05 PM | ACADIA Pharmaceuticals (Issuer) Thompson Elizabeth H.Z. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2024 3:13 PM | ACADIA Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/11/2024 5:00 PM | ACADIA Pharmaceuticals (Issuer) Schneyer Mark C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 5:00 PM | ACADIA Pharmaceuticals (Issuer) Brege Laura (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 5:00 PM | ACADIA Pharmaceuticals (Issuer) SOLAND DANIEL B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 5:00 PM | ACADIA Pharmaceuticals (Issuer) HARRIGAN EDMUND (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 5:00 PM | ACADIA Pharmaceuticals (Issuer) Daly James M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 5:00 PM | ACADIA Pharmaceuticals (Issuer) GAROFALO ELIZABETH A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 5:00 PM | ACADIA Pharmaceuticals (Issuer) Ndu Adora (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:23 PM | ACADIA Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/03/2024 5:00 PM | ACADIA Pharmaceuticals (Issuer) Kihara James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2024 5:00 PM | ACADIA Pharmaceuticals (Issuer) Teehan Brendan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2024 5:00 PM | ACADIA Pharmaceuticals (Issuer) Schneyer Mark C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/26/2024 3:21 PM | ACADIA Pharmaceuticals (Filer)
| Form DEF 14A | |
04/15/2024 5:00 PM | ACADIA Pharmaceuticals (Issuer) Thompson Elizabeth H.Z. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/09/2024 5:00 PM | ACADIA Pharmaceuticals (Issuer) Schneyer Mark C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Watch This Robotics Demo Before March 17th (Ad) Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… |
04/09/2024 5:00 PM | ACADIA Pharmaceuticals (Issuer) Kihara James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2024 5:00 PM | ACADIA Pharmaceuticals (Issuer) Teehan Brendan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2024 5:00 PM | ACADIA Pharmaceuticals (Issuer) DAVIS STEPHEN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 6:58 PM | ACADIA Pharmaceuticals (Issuer) DAVIS STEPHEN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 7:00 PM | ACADIA Pharmaceuticals (Issuer) Teehan Brendan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 7:02 PM | ACADIA Pharmaceuticals (Issuer) Kihara James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 6:57 PM | ACADIA Pharmaceuticals (Issuer) Schneyer Mark C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 5:07 PM | ACADIA Pharmaceuticals (Issuer) Kihara James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 5:10 PM | ACADIA Pharmaceuticals (Issuer) Teehan Brendan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 5:13 PM | ACADIA Pharmaceuticals (Issuer) Schneyer Mark C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |